Farmakis D - Search Results

1

The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.

Angastiniotis M, Petrou M, Loukopoulos D, Modell B, Farmakis D, Englezos P, Eleftheriou A. Angastiniotis M, et al. Among authors: farmakis d. Hemoglobin. 2021 Jan;45(1):5-12. doi: 10.1080/03630269.2021.1872612. Epub 2021 Jan 18. Hemoglobin. 2021. PMID: 33461349

2

Doppler-determined peak systolic tricuspid pressure gradient in persons with normal pulmonary function and tricuspid regurgitation.

Aessopos A, Farmakis D, Taktikou H, Loukopoulos D. Aessopos A, et al. Among authors: farmakis d. J Am Soc Echocardiogr. 2000 Jul;13(7):645-9. doi: 10.1067/mje.2000.104535. J Am Soc Echocardiogr. 2000. PMID: 10887347

3

Cardiac involvement in thalassemia intermedia: a multicenter study.

Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, Joussef J, Rombos J, Loukopoulos D. Aessopos A, et al. Among authors: farmakis d. Blood. 2001 Jun 1;97(11):3411-6. doi: 10.1182/blood.v97.11.3411. Blood. 2001. PMID: 11369631 Free article.

4

Exercise-induced myocardial perfusion abnormalities in sickle beta-thalassemia: Tc-99m tetrofosmin gated SPECT imaging study.

Aessopos A, Tsironi M, Vassiliadis I, Farmakis D, Fountos A, Voskaridou E, Perakis A, Defteraios S, Loutradi A, Loukopoulos D. Aessopos A, et al. Among authors: farmakis d. Am J Med. 2001 Oct 1;111(5):355-60. doi: 10.1016/s0002-9343(01)00835-x. Am J Med. 2001. PMID: 11583637

5

Elastic tissue abnormalities in inherited haemolytic syndromes.

Aessopos A, Farmakis D, Loukopoulos D. Aessopos A, et al. Among authors: farmakis d. Eur J Clin Invest. 2002 Sep;32(9):640-2. doi: 10.1046/j.1365-2362.2002.01033.x. Eur J Clin Invest. 2002. PMID: 12486861 No abstract available.

6

The changing epidemiology of the ageing thalassaemia populations: A position statement of the Thalassaemia International Federation.

Farmakis D, Giakoumis A, Angastiniotis M, Eleftheriou A. Farmakis D, et al. Eur J Haematol. 2020 Jul;105(1):16-23. doi: 10.1111/ejh.13410. Epub 2020 Apr 15. Eur J Haematol. 2020. PMID: 32198891 Review.

7

COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation.

Farmakis D, Giakoumis A, Cannon L, Angastiniotis M, Eleftheriou A. Farmakis D, et al. Eur J Haematol. 2020 Oct;105(4):378-386. doi: 10.1111/ejh.13476. Epub 2020 Jul 13. Eur J Haematol. 2020. PMID: 32573838 Free PMC article. Review.

8

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.

Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. Farmakis D, et al. Hemasphere. 2022 Jul 29;6(8):e732. doi: 10.1097/HS9.0000000000000732. eCollection 2022 Aug. Hemasphere. 2022. PMID: 35928543 Free PMC article.

9

Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation.

Farmakis D, Angastiniotis M, El Ghoul MM, Cannon L, Eleftheriou A. Farmakis D, et al. Hemoglobin. 2022 Jul;46(4):225-232. doi: 10.1080/03630269.2022.2099285. Epub 2022 Aug 24. Hemoglobin. 2022. PMID: 36000583 Review.

10

Heart disease in thalassemia intermedia.

Aessopos A, Tsironi M, Andreopoulos A, Farmakis D. Aessopos A, et al. Among authors: farmakis d. Hemoglobin. 2009;33 Suppl 1:S170-6. doi: 10.3109/03630260903351676. Hemoglobin. 2009. PMID: 20001622 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page